Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction u...
Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial
About this item
Full title
Author / Creator
Rikken, Sem A.O.F. , Selvarajah, Abi , Hermanides, Renicus S. , Coller, Barry S. , Gibson, C. Michael , Granger, Christopher B. , Lapostolle, Frédéric , Postma, Sonja , van de Wetering, Henri , van Vliet, Risco C.W. , Montalescot, Gilles , ten Berg, Jurriën M. , van ’t Hof, Arnoud W.J. and CELEBRATE investigators
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Early and complete restoration of target vessel patency in ST-elevation myocardial infarction (STEMI) is associated with improved outcomes. Oral P2Y12 inhibitors have failed to demonstrate either improved patency or reduced mortality when administered in the prehospital setting. Thus, there is a need for antiplatelet agents that achieve prompt and...
Alternative Titles
Full title
Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2760547885
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2760547885
Other Identifiers
ISSN
0002-8703
E-ISSN
1097-6744
DOI
10.1016/j.ahj.2022.12.015
